Results from the first feasibility study of an advanced first-generation artificial pancreas system were presented at the American Diabetes Association Meeting in Philadelphia and findings from the study indicated that the Hypoglycemia-Hyperglycemia Minimizer (HHM) System was able to automatically predict a rise and fall in blood glucose and correspondingly increase and/or decrease insulin delivery safely. Currently the most effective method of measuring blood glucose levels is with a blood glucose meter from Dexcom or other suppliers.
The HHM System included a continuous, subcutaneous insulin pump, a continuous glucose monitor (CGM) and special software used to predict changes in blood glucose.